Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2− Tumor Related to Lymphangioleiomyomatosis
Authors:
- 1 July 2016
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 186 (7) , 1825-1836
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01GM111116)
This publication has 87 references indexed in Scilit:
- Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental modelsBMC Cancer, 2013
- Unrestrained Mammalian Target of Rapamycin Complexes 1 and 2 Increase Expression of Phosphatase and Tensin Homolog Deleted on Chromosome 10 to Regulate Phosphorylation of Akt KinaseJournal of Biological Chemistry, 2012
- Efficacy and Safety of Sirolimus in LymphangioleiomyomatosisNew England Journal of Medicine, 2011
- Non‐canonical functions of the tuberous sclerosis complex‐Rheb signalling axisEMBO Molecular Medicine, 2011
- Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentationJournal of Experimental Medicine, 2010
- mTOR Activation, Lymphangiogenesis, and Estrogen-Mediated Cell Survival: The “Perfect Storm” of Pro-Metastatic Factors in LAM PathogenesisLymphatic Research and Biology, 2010
- Src Induces Podoplanin Expression to Promote Cell MigrationJournal of Biological Chemistry, 2010
- TSC2 Deficiency Increases PTEN via HIF1αJournal of Biological Chemistry, 2009
- Estrogen promotes the survival and pulmonary metastasis of tuberin-null cellsProceedings of the National Academy of Sciences, 2009
- Lack of lymphatic vessel phenotype in LYVE‐1/CD44 double knockout miceJournal of Cellular Physiology, 2009